Showing results (1381-1390 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|December 15, 2018
Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinomaJiajun Wang, Li Liu, Qi Bai, et al.Oncoimmunology|December 15, 2018
Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cellsJulia Krombach, Roman Hennel, Nikko Brix, et al.Oncoimmunology|November 18, 2017
TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancerAgnes Ling, Anna Löfgren-Burström, Pär Larsson, et al.Oncoimmunology|November 18, 2017
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancerZhong-Yi Dong, Jia-Tao Zhang, Si-Yang Liu, et al.Oncoimmunology|November 18, 2017
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survivalIrene Y Cheung, Brian H Kushner, Shakeel Modak, et al.Oncoimmunology|November 18, 2017
High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patientsYu Zhu, Zheng Liu, Yiwei Wang, et al.Oncoimmunology|November 18, 2017
Trial Watch: Adoptively transferred cells for anticancer immunotherapyCarole Fournier, François Martin, Laurence Zitvogel, et al.Oncoimmunology|November 18, 2017
Trial watch: Immune checkpoint blockers for cancer therapyClaire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, et al.Oncoimmunology|June 28, 2021
Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancerArjan Kol, Joyce M Lubbers, Anouk L J Terwindt, et al.Oncoimmunology|June 1, 2022
TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapyK O McNerney, S Karageorgos, G M Ferry, et al.Pageof 380